New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 10, 2014
10:49 EDTCERUCerulean 8.5M share IPO priced at $7
04/10/14--The deal size was raised to 8.5M from 5M shares and priced below the $11-$13 range. Leerink acted as lead book running manager for the offering.
News For CERU From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 3, 2015
07:05 EDTCERUCerulean announces research agreement with GOG for CRLX101
Cerulean Pharma announced it has signed a clinical research agreement with the GOG Foundation to conduct an open-label Phase 1b clinical trial of its lead product candidate, CRLX101, in combination with weekly paclitaxel in patients with relapsed ovarian cancer. Cerulean and the GOG Foundation have commenced start-up procedures and expect to enroll the first patient in Q2. This trial is being conducted by Cerulean in collaboration with the GOG Foundation under the direction of principal investigator Carolyn Krasner, M.D., of the Massachusetts General Hospital Cancer Center.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use